10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2015 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2015 10-K (Filed: Feb 9, 2016) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
| Cash flows from operating activities: | |||
| Cash receipts from customers | $ 148,954 | 132,406 | 114,993 |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies | (122,498) | (105,362) | (91,178) |
| Cash paid to other suppliers and employees | (14,162) | (15,344) | (14,295) |
| Interest received | 21 | 15 | 8 |
| Interest paid | (629) | (647) | (534) |
| Income taxes paid | (3,274) | (2,931) | (3,211) |
| Net cash provided by operating activities | 8,412 | 8,137 | 5,783 |
| Cash flows from investing activities: | |||
| Purchases of property and equipment | (2,367) | (2,136) | (1,984) |
| Proceeds from sale-leaseback transactions | 411 | 515 | 600 |
| Proceeds from sale of property and equipment and other assets | 35 | 11 | 54 |
| Acquisitions (net of cash acquired) and other investments | (11,475) | (2,439) | (415) |
| Purchase of available-for-sale investments | (267) | (157) | (226) |
| Maturity of available-for-sale investments | 243 | 161 | 136 |
| Net cash used in investing activities | (13,420) | (4,045) | (1,835) |
| Cash flows from financing activities: | |||
| Increase (decrease) in short-term debt | (685) | 685 | (690) |
| Proceeds from issuance of long-term debt | 14,805 | 1,483 | 3,964 |
| Repayments of long-term debt | (2,902) | (3,100) | 0 |
| Payment of contingent consideration | (58) | 0 | 0 |
| Dividends paid | (1,576) | (1,288) | (1,097) |
| Proceeds from exercise of stock options | 299 | 421 | 500 |
| Excess tax benefits from stock-based compensation | 127 | 106 | 62 |
| Repurchase of common stock | (5,001) | (4,001) | (3,976) |
| Other | (3) | 0 | 0 |
| Net cash provided by (used in) financing activities | 5,006 | (5,694) | (1,237) |
| Effect of exchange rate changes on cash and cash equivalents | (20) | (6) | 3 |
| Net increase (decrease) in cash and cash equivalents | (22) | (1,608) | 2,714 |
| Cash and cash equivalents at the beginning of the year | 2,481 | 4,089 | |
| Cash and cash equivalents at the end of the year | 2,459 | 2,481 | 4,089 |
| Reconciliation of net income to net cash provided by operating activities: | |||
| Net income | 5,239 | 4,644 | 4,592 |
| Adjustments required to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 2,092 | 1,931 | 1,870 |
| Stock-based compensation | 230 | 165 | 141 |
| Loss on early extinguishment of debt | 0 | 521 | 0 |
| Deferred income taxes and other noncash items | (266) | (58) | (86) |
| Change in operating assets and liabilities, net of effects from acquisitions: | |||
| Accounts receivable, net | (1,594) | (737) | (2,210) |
| Inventories | (1,141) | (770) | 12 |
| Other current assets | 355 | (383) | 105 |
| Other assets | 2 | 9 | (135) |
| Accounts payable and claims and discounts payable | 2,834 | 1,742 | 1,024 |
| Accrued expenses | 765 | 1,060 | 471 |
| Other long-term liabilities | (104) | 13 | (1) |
| Net cash provided by operating activities | 8,412 | 8,137 | 5,783 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2015 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |